LONDON BROKER RATINGS: BofA cuts British Land; RBC raises Gym Group
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 1,816.00p on 19-01-2026 at 16:52:02 |
|---|---|
| Change | -0.50p -0.03% |
| Buy | 1,803.50p |
| Sell | 1,803.00p |
| Last Trade: | Sell 188,139.00 at 1,813.22p |
| Day's Volume: | 5,056,429 |
| Last Close: | 1,816.00p |
| Open: | 1,800.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,793.00p - 1,816.00p |
| 52wk Range: | 1,242.50p - 1,909.50p |
| Market Capitalisation: | £73.26b |
| VWAP: | 1,808.25617p |
| Shares in Issue: | 4.03b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 188,139 | 1,813.22p | SI Trade Suspected SELL Trade |
16:52:01 - 19-Jan-26 |
| Buy* | 38,660 | 1,816.00p | Automatic Execution |
16:37:25 - 19-Jan-26 |
| Buy* | 11,340 | 1,816.00p | Automatic Execution |
16:37:25 - 19-Jan-26 |
| Buy* | 1,804,697 | 1,816.00p | Suspected BUY Trade |
16:35:01 - 19-Jan-26 |
| Buy* | 7 | 1,803.50p | SI Trade |
16:29:55 - 19-Jan-26 |
| Buy* | 479 | 1,803.00p | Automatic Execution |
16:29:48 - 19-Jan-26 |
| Buy* | 1,126 | 1,803.00p | Automatic Execution |
16:29:48 - 19-Jan-26 |
| Buy* | 505 | 1,803.00p | Automatic Execution |
16:29:48 - 19-Jan-26 |
| Buy* | 1,631 | 1,803.00p | Automatic Execution |
16:29:42 - 19-Jan-26 |
| Buy* | 556 | 1,803.00p | Automatic Execution |
16:29:42 - 19-Jan-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 15th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 7th Jan 2026 7:05 am | RNS | EC approval of Shingrix PFS |
| 7th Jan 2026 7:00 am | RNS | Positive phase 3 data for GSK's bepirovirsen |
| 6th Jan 2026 7:00 am | RNS | Exdensur approved in Japan |
| 5th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 5th Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 5th Jan 2026 7:00 am | RNS | Nucala for adults with COPD approved in China |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |